• Mashup Score: 1
    Home | KCJ - 4 year(s) ago

    × Subscription Sign Up Sign Up Feel free to choose as many as you like. Newsletter Print Copy of KCJ electronic KCJ Terms of Service * …

    Tweet Tweets with this article
    • 📢JUST IN: New Issue Available. 🔓#FreeAccess https://t.co/k1lvB97lVF Topics: 👉Tissue-based biomarkers - ASPEN trial 👉The Pathway of Belzutifan 👉Evolving Therapeutic RCC Paradigm 👉Expert Perspectives 👉Medical Intel, JC etc #MedTwitter #KidneyCancer https://t.co/mrnhzO3yex

  • Mashup Score: 1

    https://doi.org/10.52733/kcj19n3-a1 Received on 29 September 2021. Accepted for Publication on 11 October 2021. Available Online 13 October 2021 Susan Halabi, PhD1Qian Yang1, Andrea Carmack, MB1, Shiqi Zhang1, Wen-Chi Foo1,Tim Eisen, MD2, Walter M. Stadler, MD3, Robert J. Jones MD,4, Jorge…

    Tweet Tweets with this article
    • 📢JUST IN: Tissue-based biomarkers in non-clear cell RCC: Correlative analysis from the ASPEN clinical trial. 👉https://t.co/A82IbzVyUq #MedTwitter #KidneyCancer #ASPENtrial https://t.co/bFsAHhaxeS

  • Mashup Score: 1

    × Subscription Sign Up Sign Up Feel free to choose as many as you like. Newsletter Print Copy of KCJ electronic KCJ Terms of Service * …

    Tweet Tweets with this article
    • KCJ welcomes manuscript submissions in kidney cancer discipline from physicians/researchers worldwide. Submit Here: https://t.co/H9Gw4wajOo For Author Guidelines: https://t.co/h2rdeRfCtI https://t.co/KV2YUpd3hx

  • Mashup Score: 3

    × Subscription Sign Up Sign Up Feel free to choose as many as you like. Newsletter Print Copy of KCJ electronic KCJ Terms of Service * Agree to…

    Tweet Tweets with this article
    • 📢ONLINE NOW: KCJ Supplement #ASCO21 #KidneyCancer Special coverage available #FreeAccess 👉https://t.co/ZEdZmbhIJw #MedTwitter #RenalCellCarcinoma https://t.co/I3RJ4N3y3w

  • Mashup Score: 6

    https://doi.org/10.52733/KCJ19n2-a2 Renal Cell Carcinoma Associated with Germline Mutations in the Krebs Cycle Eric Lu 1, Brian Shuch,2, Alexandra Drakaki1,2 1 Division of Hematology/Oncology, University of California, Los Angeles, Los Angeles, CA, USA; 2 Institute of Urologic Oncology, University of California Los Angeles, Los Angeles, CA, USA; …

    Tweet Tweets with this article
    • 📢ONLINE NOW - Renal Cell Carcinoma Associated with Germline Mutations in the Krebs Cycle. Eric Lu , Brian Shuch, Alexandra Drakaki et al. 🔓#FreeAccess: https://t.co/Kyx6inXw5b #RenalCellCarcinoma #KidneyCancer #MedTwitter https://t.co/552ArvJ1my

  • Mashup Score: 1

    Robert J. Motzer, MD¹, Eric A. Jonasch, MD2,Bradley A. McGregor, MD3, Robert A. Figlin, MD, FACP4 1 Memorial Sloan Kettering Cancer Center (MSKCC), Weill Cornell Medical College in New York, New York; 2 Department of Genitourinary Medical Oncology, Division of Cancer Medicine, MD Anderson Cancer Center; 3 Lank Center for Genitourinary Oncology at Dana Farber Cancer…

    Tweet Tweets with this article
    • ROUNDTABLE DISCUSSION Changes, Challenges and Opportunities in Cancer Care During the COVID-19 Era and Beyond: Building on Lessons Learned From the Pandemic https://t.co/la5fhNFSG4 #clinicaltrials #kidneycancer #RCC #renalcancer #medtwitter #COVID19 #cancercare https://t.co/LVbRZNU5KN

  • Mashup Score: 4
    ASCO21 | KCJ - 4 year(s) ago

    These recommended abstracts have been selected by Robert A. Figlin, MD, Editor-in- Chief of the Kidney Cancer Journal. The chosen abstracts provided here highlight some of the most important trends in ongoing trials and reflect the foremost research and strategies from latest clinical trials that impact the current…

    Tweet Tweets with this article
    • RT @KidneyCancerJ: ASCO21: RECOMMENDED ABSTRACTS in Renal Cancer By Robert A Figlin, MD https://t.co/LNzAJytPyW #ASCO21 #MedTwitter @ASC…

    • ASCO21: RECOMMENDED ABSTRACTS in Renal Cancer By Robert A Figlin, MD https://t.co/LNzAJytPyW #ASCO21 #MedTwitter @ASCO @CedarsSinai https://t.co/e4QJFSbwFP

  • Mashup Score: 0
    Home | KCJ - 4 year(s) ago

    × Subscription Sign Up Sign Up Feel free to choose as many as you like. Newsletter Print Copy of KCJ electronic KCJ Terms of Service * …

    Tweet Tweets with this article
    • Our March issue is out. https://t.co/k1lvB97lVF 📖 Roundtable: TKIs Beyond 2nd-Line Therapy 📖 Cytoreductive Partial Nephrectomy in Met RCC setting 📖 Aberrant HIF signaling orchestrates metabolic reprogramming 📖 Journal Club 📖 Medical Intelligence 📖 Editor's Memo & more https://t.co/R21oGbnhwS

  • Mashup Score: 0
    Roundtable | KCJ - 4 year(s) ago

    ¹Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN; 2Charles A. Sammons Cancer Center, Texas AM College of Medicine, Dallas, TX; 3Cedars-Sinai Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Health System, Los Angeles, CA ABSTRACT …

    Tweet Tweets with this article
    • 𝙍𝙤𝙪𝙣𝙙𝙩𝙖𝙗𝙡𝙚: TKIs ʙᴇʏᴏɴᴅ 2ɴᴅ-ʟɪɴᴇ ᴛʜᴇʀᴀᴘʏ: ɴᴇᴡ ᴘᴇʀꜱᴘᴇᴄᴛɪᴠᴇꜱ ɪɴ ʀᴇɴᴀʟ ᴄᴇʟʟ ᴄᴀʀᴄɪɴᴏᴍᴀ ᴛʜᴇʀᴀᴘᴇᴜᴛɪᴄꜱ Full Transcript: https://t.co/p5q3EpBVOd @brian_rini @DrTHut & Robert Figlin #KidneyCancer #RenalCellCarcinoma #MedTwitter https://t.co/OzCmbgBlZl

  • Mashup Score: 3

    ¹Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN; 2Charles A. Sammons Cancer Center, Texas AM College of Medicine, Dallas, TX; 3Cedars-Sinai Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Health System, Los Angeles, CA …

    Tweet Tweets with this article
    • Webinar: TKIs ʙᴇʏᴏɴᴅ 2ɴᴅ-ʟɪɴᴇ ᴛʜᴇʀᴀᴘʏ: ɴᴇᴡ ᴘᴇʀꜱᴘᴇᴄᴛɪᴠᴇꜱ ɪɴ ʀᴇɴᴀʟ ᴄᴇʟʟ ᴄᴀʀᴄɪɴᴏᴍᴀ ᴛʜᴇʀᴀᴘᴇᴜᴛɪᴄꜱ https://t.co/T1X2lWHJQK @brian_rini @DrTHut & Robert Figlin, MD #RenalCancer #RenalCellCarcinoma #KidneyCancerAwarenessMonth #MedTwitter https://t.co/8WXrrmqGDz